Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.
Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей
Yawei Luo
Drug Repurposing opportunities arise from potential observations, discussions, and collaborations, including the development of different meaningful platforms for the identification of drugs and their potential targets and allow the accessing of compounds. Drug Repurposing is an approach that uses the existing approved/failed drug for novel clinical use. This approach has the advantage that the compounds have already undergone different drug discovery phases and have sufficient information related to safety, efficacy, formulation, dose, and potential toxicity. As a result, this strategy is gaining considerable attention in drug research because of its cost-effective and time-saving capabilities. In recent years many pharmaceuticals are utilizing this approach for their drug discovery and development program, in fact in the Covid-19 era, its utility increased by many folds.